Litigation Details for FOREST LABORATORIES, LLC v. WEST-WARD PHARMACEUTICALS INTERNATIONAL LIMITED (D.N.J. 2017)
✉ Email this page to a colleague
FOREST LABORATORIES, LLC v. WEST-WARD PHARMACEUTICALS INTERNATIONAL LIMITED (D.N.J. 2017)
Docket | ⤷ Try a Trial | Date Filed | 2017-10-31 |
Court | District Court, D. New Jersey | Date Terminated | 2018-02-08 |
Cause | 35:271 Patent Infringement | Assigned To | Esther Salas |
Jury Demand | None | Referred To | Michael A. Hammer |
Patents | 8,481,598; 8,865,937; RE43,879 | ||
Link to Docket | External link to docket |
Small Molecule Drugs cited in FOREST LABORATORIES, LLC v. WEST-WARD PHARMACEUTICALS INTERNATIONAL LIMITED
Details for FOREST LABORATORIES, LLC v. WEST-WARD PHARMACEUTICALS INTERNATIONAL LIMITED (D.N.J. 2017)
Date Filed | Document No. | Description | Snippet | Link To Document |
---|---|---|---|---|
2017-10-31 | 1 | United States Patent Nos. 8,481,598 (“the ’598 patent”), 8,865,937 (“the ’937 patent”), and RE43,879… said patents under 35 U.S.C. § 271(a); d) declare that United States Patent Nos. 8,481,598, 8,865,937… infringed United States Patent Nos. 8,481,598, 8,865,937, and RE43,879 by submitting ANDA…levomilnacipran products before United States Patent Nos. 8,481,598 and RE43,879 expire, would constitute…expiration date of United States Patent Nos. 8,481,598, 8,865,937, and RE43,879, including any | External link to document | |
>Date Filed | >Document No. | >Description | >Snippet | >Link To Document |